This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cutlip, D. E. Articles by Kuntz, R. E. Search for Related Content PubMed PubMed Citation Articles by Cutlip, D. E. Articles by Kuntz, R. E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Angioplasty

(Circulation. 2005;112:916-923.)
© 2005 American Heart Association, Inc.

Controversies in Cardiovascular Medicine

Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes

Donald E. Cutlip, MD; Richard E. Kuntz, MD, MSc

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The debate over the importance of periprocedural creatinine kinase-myocardial band (CK-MB) elevation after percutaneous coronary intervention (PCI) has captured the attention of cardiologists since the early days of balloon angioplasty, when the phenomenon was first recognized and reported to have no clear association with adverse clinical sequelae.^1,2 These early reports were limited by the small numbers of patients and follow-up that extended only to hospital discharge. Since then there have been numerous published studies documenting the frequency and clinical outcomes of periprocedural CK-MB elevation, most of which have implicated it in a clear relationship to later adverse outcome including increased mortality.^3–9 Multiple additional reports of this adverse association have been presented only in abstract form. Moreover, previous controversies about whether these enzyme elevations actually represent myocardial infarction (MI) have been dismissed by clear evidence demonstrating myocardial necrosis in the zones of the target vessel after PCI accompanied by CK-MB elevation.¹⁰ The consistency of these findings has led to widespread acceptance of a deleterious role for periprocedural MI,¹¹ and moderate elevations of CK-MB (>3 times the upper limit of normal [ULN]) have been regarded by many as appropriate surrogate end points for studies of coronary interventional devices and antithrombotic drug therapy. Still, some investigators have not found an association or have reported adverse outcomes only after large MI (CK-MB >5 to 10 times the ULN) or with a concurrent procedural complication for which the survival consequences are not debated.^12–15

The fact that the debate continues at national meetings and has been . . . [Full Text of this Article]

This article has been cited by other articles:

				K Rahimi, A P Banning, A S H Cheng, T J Pegg, T D Karamitsos, K M Channon, S Darby, D P Taggart, S Neubauer, and J B Selvanayagam Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study Heart, December 1, 2009; 95(23): 1937 - 1943. [Abstract] [Full Text] [PDF]

				A Kumar and D H Roberts Immediate versus deferred coronary angioplasty in non-ST-elevation acute coronary syndromes Heart, September 1, 2009; 95(17): 1455 - 1456. [Full Text] [PDF]

				A. Prasad, B. J. Gersh, M. E. Bertrand, A. M. Lincoff, J. W. Moses, E. M. Ohman, H. D. White, S. J. Pocock, B. T. McLaurin, D. A. Cox, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 477 - 486. [Abstract] [Full Text] [PDF]

				D. A. Morrow, S. D. Wiviott, H. D. White, J. C. Nicolau, E. Bramucci, S. A. Murphy, M. P. Bonaca, C. T. Ruff, B. M. Scirica, C. H. McCabe, et al. Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38: An Application of the Classification System From the Universal Definition of Myocardial Infarction Circulation, June 2, 2009; 119(21): 2758 - 2764. [Abstract] [Full Text] [PDF]

				E. M. Antman and D. A. Morrow Biomarker Release After Percutaneous Coronary Intervention: A Message From the Heart Circ Cardiovasc Interv, August 1, 2008; 1(1): 3 - 6. [Full Text] [PDF]

				A. Prasad, C. S. Rihal, R. J. Lennon, M. Singh, A. S. Jaffe, and D. R. Holmes Jr Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients Circ Cardiovasc Interv, August 1, 2008; 1(1): 10 - 19. [Abstract] [Full Text] [PDF]

				N. S. Kleiman Measuring Troponin Elevation After Percutaneous Coronary Intervention: Ready for Prime Time? J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1771 - 1773. [Full Text] [PDF]

				D. L. Bhatt Shifting the Diagnosis of Periprocedural Myocardial Infarction Upstream Circulation, October 31, 2006; 114(18): 1898 - 1900. [Full Text] [PDF]